1. Home
  2. GMEX vs ENSC Comparison

GMEX vs ENSC Comparison

Compare GMEX & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GMEX

GMEX ROBOTICS CORPORATION Class A Ordinary Shares

N/A

Current Price

$0.79

Market Cap

1.7M

ML Signal

N/A

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$0.25

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMEX
ENSC
Founded
2005
2003
Country
Australia
United States
Employees
16
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
1.7M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GMEX
ENSC
Price
$0.79
$0.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.8M
887.9K
Earning Date
04-17-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$55.01
Revenue Next Year
N/A
$1,033.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.23
52 Week High
$2.50
$2.75

Technical Indicators

Market Signals
Indicator
GMEX
ENSC
Relative Strength Index (RSI) 34.77 37.26
Support Level $0.35 $0.23
Resistance Level $1.25 $0.32
Average True Range (ATR) 0.27 0.03
MACD -0.11 0.00
Stochastic Oscillator 3.96 23.00

Price Performance

Historical Comparison
GMEX
ENSC

About GMEX GMEX ROBOTICS CORPORATION Class A Ordinary Shares

GMEX Robotics Corp is engaged in the design and deployment of AI-powered robotics and intelligent consumer technologies. The group operates in three business areas: Consumer and Commercial Robotics: Developing intuitive and interactive robots designed to assist with daily tasks, provide smart home integration, and offer new levels of convenience and connectivity to boost productivity; AI-Driven Hardware: Embedding artificial intelligence into physical products to create self-learning and adaptive user experiences; and Innovation & Ecosystem: Building a robust ecosystem of robotic products that communicate and evolve, powered by proprietary AI algorithms.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: